A Study of Baricitinib (LY3009104) in Children With COVID-19

PHASE3RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 21, 2021

Primary Completion Date

April 30, 2026

Study Completion Date

May 31, 2026

Conditions
Covid19Corona Virus Infection
Interventions
DRUG

Baricitinib

Given Orally

Trial Locations (14)

28041

RECRUITING

Hospital Universitario 12 de Octubre, Madrid

28046

ACTIVE_NOT_RECRUITING

Hospital Universitario La Paz, Madrid

31009

ACTIVE_NOT_RECRUITING

Complejo Hospitalario de Navarra, Pamplona

32806

RECRUITING

Arnold Palmer Hospital for Children, Orlando

44106

ACTIVE_NOT_RECRUITING

University Hospitals Cleveland Medical Center, Cleveland

48201

RECRUITING

Children's Hospital of Michigan, Detroit

17201130

RECRUITING

CECIP - Centro de Estudos do Interior Paulista, Jaú

90410000

RECRUITING

Hospital de Clinicas de Porto Alegre, Porto Alegre

13034-685

RECRUITING

Centro de Pesquisa Sao Lucas, Campinas

13060-080

RECRUITING

Instituto de Pesquisa clinica de Campinas, Campinas

09080-110

RECRUITING

Pesquisare Saude, Santo André

04530

RECRUITING

Instituto Nacional de Pediatria, Mexico City

06720

RECRUITING

Hospital Infantil de Mexico Federico Gomez, Mexico City

01009

RECRUITING

Hospital Universitario de Araba (HUA)- Hospital Txagorritxu, Vitoria-Gasteiz

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY